United Kingdom
www.gwpharm.com
GW Pharmaceuticals lead product, Sativex®, is approved in over 20 countries and the company has a highly promising pipeline of additional cannabinoid drug candidates in development.
Our vision... is to be the global leaders in prescription cann ...
Tweets by @InvestinginMJ